Jianfeng Hong | Fresenius Kabi |USA | Parenterals 2015 | Conference Series LLC
International Conference and Expo onParenterals & Injectables, August 17-19, 2015 Chicago, USA
Scientific Talk On: Extractable and leachable studies of parenteral infusion and transfusion products
Click here for Abstract and Biography: http://parenterals-injectables.pharmaceuticalconferences.com/abstract/2015/extractable-and-leachable-studies-of-parenteral-infusion-and-transfusion-products
Conference Series LLC (3000+ Global Events): conferenceseries.com
Global Medical Conferences: conferenceseries.com
Global Nursing Conferences: nursingconference.com
Global Pharmaceutical Conferences: pharmaceuticalconferences.com
Global Cancer Conferences: cancersummit.org
Global Diabetes Conferences: diabetesexpo.com
Global Dental Conferences: dentalcongress.com
700+ Open Access Journals: omicsonline.org
Jianfeng Hong is a Senior Research Scientist and the Manager of the Analytical Chemistry laboratory at Lake Zurich, Illinois of Fresenius Kabi USA LLC. His major responsibilities include leading a group of analytical chemists to perform extractable and leachable testings, as parts of biocompatibility studies for material characterizations, for transfusion and infusion products of blood and pharmaceuticals of Fresenius Kabi. His group uses a wide variety of advanced analytical instrumentation including GC/ MS, UPLC/UV, Q-TOF mass spectrometer with accurate mass capability, ICP and TOC. He has over eighteen year experience as an analytical chemist with pharmaceutical and medical device industries. He earned a Master’s degree in Analytical Chemistry from University of Louisville, Kentucky, USA.
This presentation will describe the general extractable/ leachable study practices of parenteral infusion and transfusion products. It will include (1) extractable and leachable study designs and extractable/leachable study work fl ows using a wide variety of analytical techniques (UPLC/UV/MS, GC/MS, ICP and TOC). (2) Th e determinations of concentration thresholds for extractable and leachable that require identifi cation and quantifi cation (3) risk assessments of the extractable and leachable compounds and (4). Selection and analytical method development/validation is carried out for target leachable compounds that are monitored for the stability evaluation of infusion and transfusion products.